Stay updated on Bempeg+Nivo vs TKI in Adv RCC: Clinical Trial
Sign up to get notified when there's something new on the Bempeg+Nivo vs TKI in Adv RCC: Clinical Trial page.

Latest updates to the Bempeg+Nivo vs TKI in Adv RCC: Clinical Trial page
- Check4 days agoChange DetectedThe record now presents details of the phase 3 renal cell carcinoma study, including its terminated status, treatments, eligibility criteria, outcomes, results, and study locations.SummaryDifference98%

- Check11 days agoChange DetectedThe footer revision changed from v3.7.2 to v3.8.0, while the page continues to show a 403 Forbidden error.SummaryDifference0.2%

- Check18 days agoChange DetectedA site-wide notice announces an NIH transition in terminology from “Artificial Intelligence” to “Super Intelligence” and links to updates and FAQs.SummaryDifference1%

- Check25 days agoChange DetectedThe ClinicalTrials.gov page continues to show a 403 error instead of the study record, with the footer revision updated from v3.7.1 to v3.7.2.SummaryDifference0.2%

- Check32 days agoChange DetectedThe footer’s revision identifier changed from v3.7.0 to v3.7.1; the study page still displays a 403 error.SummaryDifference0.2%

- Check53 days agoChange DetectedThe Study Documents area no longer shows the Statistical Analysis Plan and Study Protocol, along with several related entries, reducing access to core protocol-level information about the trial.SummaryDifference18%

Stay in the know with updates to Bempeg+Nivo vs TKI in Adv RCC: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Bempeg+Nivo vs TKI in Adv RCC: Clinical Trial page.